Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.

Murata M, Kitamura T, Tamada D, Mukai K, Kurebayashi S, Yamamoto T, Hashimoto K, Hayashi RD, Kouhara H, Takeiri S, Kajimoto Y, Nakao M, Hamasaki T, Otsuki M, Shimomura I.

J Hypertens. 2017 May;35(5):1079-1085. doi: 10.1097/HJH.0000000000001251.

PMID:
28129245
2.

Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan.

Tabuchi Y, Otsuki M, Kasayama S, Kosugi K, Hashimoto K, Yamamoto T, Tsugawa M, Mineo I, Yamada Y, Kurebayashi S, Ohashi M, Umayahara Y, Kouhara H, Nakamura T, Taki H, Matsuoka TA, Imagawa A, Funahashi T, Shimomura I.

Endocr J. 2016;63(1):29-35. doi: 10.1507/endocrj.EJ15-0404. Epub 2015 Oct 22.

3.

High efficient and cost-effective screening method for diabetic cardiovascular risk.

Kajimoto T, Sawamura MS, Hayashi RD, Oya T, Hirao RA, Kouhara H.

Diabetol Metab Syndr. 2014 Apr 8;6(1):51. doi: 10.1186/1758-5996-6-51.

4.

Effects of pitavastatin on serum lipids and high sensitivity C-reactive protein in type 2 diabetic patients.

Motomura T, Okamoto M, Kitamura T, Yamamoto H, Otsuki M, Asanuma N, Takagi M, Kurebayashi S, Hashimoto K, Sumitani S, Saito H, Kouhara H, Nshii K, Nakao M, Koga M, Sato B, Morimoto Y, Kasayama S.

J Atheroscler Thromb. 2009 Oct;16(5):546-52. Epub 2009 Sep 3.

5.
6.

Painless thyroiditis occurring during post-menopausal period, following remission of Graves' disease.

Kasayama S, Kitamura T, Inaba M, Otsuki M, Asanuma N, Kouhara H.

J Endocrinol Invest. 2008 Jan;31(1):92-3. No abstract available.

PMID:
18296912
7.

A novel growth hormone receptor gene deletion mutation in a patient with primary growth hormone insensitivity syndrome (Laron syndrome).

Yamamoto H, Kouhara H, Iida K, Chihara K, Kasayama S.

Growth Horm IGF Res. 2008 Apr;18(2):136-42. Epub 2007 Aug 28.

PMID:
17728167
8.

Impacts of long-term treatments with testosterone replacement and pioglitazone on glucose and lipid metabolism in male patients with Werner's syndrome.

Yamamoto H, Kurebayashi S, Kouhara H, Yoshiuchi K, Matsuhisa M, Yamasaki Y, Kasayama S.

Clin Chim Acta. 2007 Apr;379(1-2):167-70. Epub 2007 Jan 18. No abstract available.

PMID:
17306780
9.

The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells.

Goya K, Sumitani S, Otsuki M, Xu X, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S.

J Diabetes Complications. 2006 Sep-Oct;20(5):336-42.

PMID:
16949522
10.

Reduction of a pancreatic tumor after total removal of an ACTH secreting pituitary tumor: differential diagnosis of Cushing's syndrome.

Hashiba T, Saitoh Y, Asanuma N, Kouhara H, Maruo T, Fujinaka T, Kasayama S, Yoshimine T.

Endocr J. 2006 Apr;53(2):203-8.

11.

A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells.

Kurebayashi S, Xu X, Ishii S, Shiraishi M, Kouhara H, Kasayama S.

Atherosclerosis. 2005 Sep;182(1):71-7. Epub 2005 Mar 4.

PMID:
16115476
12.

Regeneration of tubular complex is promoted by a free space.

Kitamura T, Asanuma N, Inaba M, Otsuki M, Kasayama S, Kouhara H, Kawase I.

Pancreas. 2005 Mar;30(2):174-9.

PMID:
15714140
13.

Suppressor of cytokine signaling 1 suppresses muscle differentiation through modulation of IGF-I receptor signal transduction.

Inaba M, Saito H, Fujimoto M, Sumitani S, Ohkawara T, Tanaka T, Kouhara H, Kasayama S, Kawase I, Kishimoto T, Naka T.

Biochem Biophys Res Commun. 2005 Mar 25;328(4):953-61.

PMID:
15707970
14.

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.

Goya K, Sumitani S, Xu X, Kitamura T, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S, Kawase I.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):658-63. Epub 2004 Jan 29.

PMID:
14751809
15.

Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications.

Goya K, Kitamura T, Inaba M, Otsuki M, Yamamoto H, Kurebayashi S, Sumitani S, Saito H, Kouhara H, Kasayama S, Kawase I.

Metabolism. 2003 Oct;52(10):1302-6.

PMID:
14564682
16.

New analytical method for pancreas and liver regeneration: normalization of streptozotocin-induced hyperglycemia by retrograde injection of insulin producing cells.

Asanuma N, Kitamura T, Xu X, Sumitani S, Saito H, Kasayama S, Kouhara H, Kawase I.

Endocr J. 2002 Aug;49(4):449-57.

17.

Reduced IRS-2 and GLUT4 expression in PPARgamma2-induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse embryonic fibroblasts.

Yamamoto H, Kurebayashi S, Hirose T, Kouhara H, Kasayama S.

J Cell Sci. 2002 Sep 15;115(Pt 18):3601-7.

18.

RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor alpha on interleukin-6 production in vascular endothelial cells.

Xu X, Otsuki M, Sumitani S, Saito H, Kouhara H, Kasayama S.

J Steroid Biochem Mol Biol. 2002 Jun;81(2):141-6.

PMID:
12137803
19.

PTHrP-producing tumor: squamous cell carcinoma of the liver accompanied by humoral hypercalcemia of malignancy, increased IL-6 and leukocytosis.

Asanuma N, Hagiwara K, Matsumoto I, Matsuda M, Nakamura F, Kouhara H, Miyamoto M, Miyashita Y, Noguchi S, Morimoto Y.

Intern Med. 2002 May;41(5):371-6. Review.

20.
21.

Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea.

Hirose T, Miyashita Y, Takagi M, Sumitani S, Kouhara H, Kasayama S.

Diabetes Res Clin Pract. 2001 Oct;54(1):9-15.

PMID:
11532325
22.

Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence.

Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kurabayashi M, Kasayama S.

Atherosclerosis. 2001 Sep;158(1):121-8.

PMID:
11500182
23.

PPARalpha and GR differentially down-regulate the expression of nuclear factor-kappaB-responsive genes in vascular endothelial cells.

Xu X, Otsuki M, Saito H, Sumitani S, Yamamoto H, Asanuma N, Kouhara H, Kasayama S.

Endocrinology. 2001 Aug;142(8):3332-9.

PMID:
11459775
24.

Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways.

Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J.

Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8578-83. Epub 2001 Jul 10.

25.

Characterization of premature atherosclerosis of carotid arteries in acromegalic patients.

Otsuki M, Kasayama S, Yamamoto H, Saito H, Sumitani S, Kouhara H, Saitoh Y, Ohnishi T, Arita N.

Clin Endocrinol (Oxf). 2001 Jun;54(6):791-6.

PMID:
11422114
26.

Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells.

Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kishimoto T, Kasayama S.

Arterioscler Thromb Vasc Biol. 2001 Feb;21(2):243-8.

PMID:
11156860
27.

Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients.

Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, Koga M, Saitoh Y, Ohnishi T, Arita N.

Clin Endocrinol (Oxf). 2000 May;52(5):549-55.

PMID:
10792333
28.
29.

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway.

Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J.

Cell. 1997 May 30;89(5):693-702.

30.

Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas.

Hashimoto K, Koga M, Motomura T, Kasayama S, Kouhara H, Ohnishi T, Arita N, Hayakawa T, Sato B, Kishimoto T.

J Clin Endocrinol Metab. 1995 Oct;80(10):2933-9.

PMID:
7559877
31.

Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase.

Kouhara H, Kurebayashi S, Hashimoto K, Kasayama S, Koga M, Kishimoto T, Sato B.

Oncogene. 1995 Jun 15;10(12):2315-22.

PMID:
7784079
32.

Unsaturated fatty acids are required for continuous proliferation of transformed androgen-dependent cells by fibroblast growth factor family proteins.

Kasayama S, Koga M, Kouhara H, Sumitani S, Wada K, Kishimoto T, Sato B.

Cancer Res. 1994 Dec 15;54(24):6441-5.

33.

Murine fibroblast growth factor receptor 1 gene generates multiple messenger RNAs containing two open reading frames via alternative splicing.

Harada T, Saito H, Kouhara H, Kurebayashi S, Kasayama S, Terakawa N, Kishimoto T, Sato B.

Biochem Biophys Res Commun. 1994 Dec 15;205(2):1057-63.

PMID:
7802632
34.
35.

Expression patterns of messenger ribonucleic acids encoding prohormone convertases (PC2 and PC3) in human pituitary adenomas.

Hashimoto K, Koga M, Kouhara H, Arita N, Hayakawa T, Kishimoto T, Sato B.

Clin Endocrinol (Oxf). 1994 Aug;41(2):185-91.

PMID:
7923822
36.

Effects of therapy on anterior pituitary functions in patients with primary intracranial germ cell tumor.

Kumanogoh A, Kasayama S, Kouhara H, Koga M, Arita N, Hayakawa T, Kishimoto T, Sato B.

Endocr J. 1994 Jun;41(3):287-92.

37.

Mapping of a transcription element critical for expression of the fibroblast growth factor receptor 1 gene.

Saito H, Kouhara H, Harada T, Miyake S, Sugiyama H, Kishimoto T, Sato B.

Biochem Biophys Res Commun. 1994 Feb 15;198(3):1020-6.

PMID:
8117257
38.

Transforming activity of a newly cloned androgen-induced growth factor.

Kouhara H, Koga M, Kasayama S, Tanaka A, Kishimoto T, Sato B.

Oncogene. 1994 Feb;9(2):455-62.

PMID:
8290257
39.

Androgen-induced growth factor and its receptor: demonstration of the androgen-induced autocrine loop in mouse mammary carcinoma cells.

Sato B, Kouhara H, Koga M, Kasayama S, Saito H, Sumitani S, Hashimoto K, Kishimoto T, Tanaka A, Matsumoto K.

J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):91-8. Review.

PMID:
8274446
40.

[Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system].

Koga M, Kouhara H, Sato B.

Hum Cell. 1993 Sep;6(3):176-81. Japanese.

PMID:
8297813
41.
42.

Intracranial and intraspinal dissemination of an ACTH-secreting pituitary tumor.

Kouhara H, Tatekawa T, Koga M, Hiraga S, Arita N, Mori H, Sato B.

Endocrinol Jpn. 1992 Apr;39(2):177-84. Review.

43.

Characterization of the promoter region of the murine fibroblast growth factor receptor 1 gene.

Saito H, Kouhara H, Kasayama S, Kishimoto T, Sato B.

Biochem Biophys Res Commun. 1992 Mar 16;183(2):688-93.

PMID:
1312839
44.

Functional abnormality of glucocorticoid receptor in Shionogi carcinoma 115 cells as evidenced by gene transfer experiments.

Hirose T, Koga M, Saito H, Kouhara H, Sumitani S, Kasayama S, Matsumoto K, Sato B.

J Steroid Biochem Mol Biol. 1991 May;38(5):593-8.

PMID:
1645588
45.

Expression cDNA cloning of fibroblast growth factor (FGF) receptor in mouse breast cancer cells: a variant form in FGF-responsive transformed cells.

Kouhara H, Kasayama S, Saito H, Matsumoto K, Sato B.

Biochem Biophys Res Commun. 1991 Apr 15;176(1):31-7.

PMID:
1708247
46.

Up-regulation of fibroblast growth factor (FGF) receptor mRNA levels by basic FGF or testosterone in androgen-sensitive mouse mammary tumor cells.

Saito H, Kasayama S, Kouhara H, Matsumoto K, Sato B.

Biochem Biophys Res Commun. 1991 Jan 15;174(1):136-41.

PMID:
1846535
47.

Effect of retinoic acid on proliferation of estrogen-responsive transformed murine Leydig cells in serum-free culture.

Hirose T, Koga M, Kouhara H, Kishimoto S, Matsumoto K, Sato B.

Cancer Res. 1990 Aug 15;50(16):5060-4.

48.

Identification of unoccupied but transformed nuclear estrogen receptor in cultured mouse Leydig cell.

Miyashita Y, Hirose T, Kouhara H, Kishimoto S, Matsumoto K, Sato B.

J Steroid Biochem. 1990 Apr;35(5):561-7.

PMID:
2355731
49.

[Regulatory mechanism of steroid hormone receptor functions].

Kouhara H, Sato B.

Gan To Kagaku Ryoho. 1987 Oct;14(10):2824-9. Japanese.

PMID:
2821924
50.

Direction of transcription affects the replication mode of lambda in an in vitro system.

Kouhara H, Tsurimoto T, Matsubara K.

Mol Gen Genet. 1987 Jul;208(3):428-35.

PMID:
2959840

Supplemental Content

Loading ...
Support Center